Altogether, this analysis shows that low expression of the GABARAP family and VAMP2 correlates with a higher risk of poorer outcome in PAAD and might serve as a good indicator of poor prognosis in KRAS-G12 bearing tumours. Here, GABARAP is linked to neoplasm.